鼻咽癌放射性脑病的Symptoms有哪些
In general, patients with radiation-induced encephalopathy following nasopharyngeal carcinoma may experience symptoms such as memory loss, difficulty concentrating, slowed reactions, headache, nausea, and vomiting. It is recommended that patients receive symptomatic treatment according to medical advice. Specific analysis is as follows:
1. Memory Loss
During radiotherapy for nasopharyngeal carcinoma, the brain's nerves may sustain some damage, leading to memory decline. Patients may also experience associated symptoms such as fatigue, insomnia, and vivid dreams. Under medical guidance, patients can take neurotrophic medications such as mecobalamin tablets or vitamin B1 tablets.
2. Difficulty Concentrating
Radiation therapy may damage cerebral nerves in patients with nasopharyngeal carcinoma, resulting in difficulty concentrating and possibly slowed thinking. It is recommended that patients use medications such as oxiracetam injection or piracetam tablets under a doctor’s supervision.
3. Slowed Reactions
Patients may also exhibit delayed responses, slower reaction to external stimuli, and in severe cases, even fall into a coma. Under medical guidance, patients can take neurotrophic drugs such as vitamin B12 tablets or oryzanol tablets.
4. Headache
After radiotherapy for nasopharyngeal carcinoma, brain tissue may be damaged, often causing headaches that can be relatively severe. Patients can follow medical advice to take medications such as ibuprofen sustained-release capsules or diclofenac sodium sustained-release tablets to relieve pain.
5. Nausea and Vomiting
Radiotherapy may cause certain gastrointestinal damage in patients with nasopharyngeal carcinoma, leading to nausea and vomiting, possibly accompanied by bloating and loss of appetite. Patients can take medications such as metoclopramide tablets or chlorpromazine hydrochloride tablets as directed by their physician to alleviate discomfort.
In addition, radiation-induced encephalopathy in nasopharyngeal carcinoma may also lead to temporary blindness. If patients experience any discomfort, they should seek prompt medical attention for timely and targeted treatment to avoid disease progression.